Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating trazodone's effect on NREM sleep stage III in patients with comorbid depression and insomnia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trazodone (trazodone)

Snippet

Sponsor: Tongji University | Conditions: Depressed Insomniac Co-morbid Patients | Phase 4 | Status: RECRUITING